Arterial disorders occur when the blood vessels carrying oxygen-rich blood throughout your body become narrowed or blocked. While these conditions can seriously impact your daily life and overall health, understanding your treatment options—from lifestyle changes to cutting-edge therapies being studied in clinical trials—can help you manage symptoms and reduce the risk of complications.

How Treatment Helps You Take Control of Arterial Disease

When you have an arterial disorder, the main goal of treatment is to improve blood flow to the parts of your body that aren’t getting enough oxygen. This means working to relieve symptoms like leg pain when walking, preventing serious complications such as heart attacks or strokes, and helping you stay active and independent in your daily life. Treatment approaches vary widely depending on which arteries are affected, how severe the blockage is, and your overall health condition^[1].

Your doctor will consider many factors when recommending treatment. These include your age, other health conditions you may have, how much the symptoms interfere with your life, and whether you have risk factors like smoking, diabetes, or high blood pressure. Some people need only lifestyle changes and medications, while others may benefit from procedures to open blocked arteries. The good news is that catching arterial disease early and starting treatment can significantly lower your risk of losing a limb or experiencing a cardiovascular emergency^[2].

Treatment isn’t just about the arteries in one part of your body. If you have blockages in your leg arteries, for example, you’re more likely to have similar problems in the arteries supplying your heart and brain. That’s why treatment usually addresses your overall cardiovascular health, not just the specific artery causing symptoms. Medical organizations have developed guidelines to help doctors provide the best care, and researchers continue studying new treatments that might work better than current options^[3].

Standard Treatment Approaches

The foundation of treating arterial disorders starts with lifestyle modifications. These changes are so powerful that they can sometimes reverse symptoms or prevent the disease from getting worse. Stopping smoking is the single most important step you can take. Smoking is the biggest risk factor for arterial disease, and people who continue smoking after diagnosis face much higher rates of heart attacks and complications compared to those who quit. It damages artery walls, promotes plaque buildup, and makes blood more likely to clot^[4].

Exercise therapy is another cornerstone of treatment, particularly for peripheral artery disease affecting the legs. This might sound counterintuitive since walking often causes pain, but supervised exercise programs have been shown to significantly improve how far you can walk and reduce discomfort. A typical program involves walking until you feel pain, resting until it goes away, then walking again. You repeat this pattern for about 30 minutes, several times per week for at least three months. Over time, your body develops new small blood vessels that help supply blood to your muscles, a process called collateral circulation. Many healthcare systems now offer supervised exercise training programs specifically designed for people with arterial disease^[6].

Medications form a critical part of treatment, targeting both symptoms and the underlying disease process. Antiplatelet drugs like aspirin or clopidogrel help prevent blood clots from forming on plaque deposits. These medications reduce your risk of heart attack and stroke by making platelets less sticky. Statins are cholesterol-lowering drugs that do more than just reduce cholesterol levels—they also stabilize plaque in artery walls, making it less likely to rupture and cause a clot. Common statins include atorvastatin, simvastatin, and rosuvastatin. Most people tolerate them well, though some experience muscle aches or digestive upset^[11].

Blood pressure control is essential in managing arterial disease. High blood pressure damages artery walls and accelerates plaque buildup. Doctors often prescribe ACE inhibitors (angiotensin-converting enzyme inhibitors) or ARBs (angiotensin receptor blockers), which not only lower blood pressure but also provide cardiovascular protection. Examples include ramipril, lisinopril, and losartan. These medications work by affecting hormones that regulate blood pressure. Side effects can include dizziness, fatigue, or a persistent dry cough with ACE inhibitors, though most people adjust to them within a few weeks^[12].

For people with diabetes, strict blood sugar control is crucial. High blood sugar levels damage artery walls and nerve endings, accelerating arterial disease and making symptoms worse. Your doctor will work with you to manage diabetes through diet, oral medications, or insulin as needed. Keeping your hemoglobin A1c level in the target range can slow disease progression^[5].

Some patients receive medications specifically to improve walking distance. Cilostazol is a drug that widens blood vessels and prevents blood clots, helping more blood reach your legs during activity. It can improve walking distance by roughly 50% in some people. However, it’s not suitable for everyone, particularly those with heart failure. Another medication called pentoxifylline is sometimes prescribed, though evidence for its effectiveness is less strong than for cilostazol^[10].

When lifestyle changes and medications aren’t enough to relieve symptoms or when blood flow becomes critically reduced, procedures or surgery may be necessary. Angioplasty is a minimally invasive procedure where doctors thread a thin tube called a catheter through your arteries to the blockage. A small balloon at the tip is inflated to compress the plaque and widen the artery. Often, a metal mesh tube called a stent is placed to keep the artery open. These procedures are done through a small puncture in your groin or arm, so recovery is much faster than with traditional surgery^[15].

For more extensive blockages, bypass surgery may be needed. This involves using a blood vessel from another part of your body—often a vein from your leg—or a synthetic tube to create a detour around the blocked section of artery. Bypass surgery requires general anesthesia and a longer recovery period, but it can be very effective for severe disease. The decision between angioplasty and bypass depends on the location and extent of blockages, your overall health, and your surgeon’s expertise^[10].

Another procedure option is atherectomy, where specialized catheters with rotating blades or lasers are used to remove plaque from inside the artery. This is particularly useful when plaque is very hard and calcified. Like angioplasty, atherectomy is minimally invasive and performed through small punctures rather than large incisions^[15].

Treatment duration varies considerably. Lifestyle modifications need to continue for life—they’re not temporary fixes but permanent changes to protect your health. Medications are typically long-term as well, though doses may be adjusted over time. The effects of angioplasty and stents can last for years, though sometimes arteries narrow again and require repeat procedures. Bypass grafts can function well for a decade or more, but maintaining them requires ongoing medication and risk factor management^[11].

Treatment in Clinical Trials

Researchers around the world are studying new approaches to treat arterial disorders, testing innovative medications and procedures that may offer better results than current options. Clinical trials are research studies that evaluate whether new treatments are safe and effective before they become widely available. Participating in a clinical trial gives patients access to cutting-edge therapies while contributing to medical knowledge that helps future patients^[4].

One promising area of research involves new medications that target specific molecular pathways involved in plaque formation and inflammation. Scientists have discovered that inflammation plays a bigger role in arterial disease than previously understood. Plaque isn’t just a passive buildup of cholesterol—it’s an active inflammatory process. Researchers are testing anti-inflammatory drugs that might slow or reverse plaque growth by calming this inflammatory response. Some trials are examining medications originally developed for other conditions, like rheumatoid arthritis, to see if they benefit arterial disease as well^[2].

Gene therapy represents an exciting frontier in arterial disease treatment. This approach involves introducing genetic material into cells to promote the growth of new blood vessels, a process called therapeutic angiogenesis. The idea is to help your body create its own natural bypasses around blocked arteries by stimulating the growth of collateral vessels. Early-phase clinical trials have tested various growth factors and gene delivery methods. While results have been mixed, researchers continue refining these techniques and identifying which patients might benefit most. Some gene therapy trials are in Phase I, focusing on safety, while others have progressed to Phase II studies examining effectiveness^[4].

Cell-based therapies are also under investigation. These trials test whether injecting certain types of cells—often stem cells or progenitor cells taken from the patient’s own bone marrow or blood—can improve blood flow and promote healing in diseased arteries. The cells may work by releasing growth factors, reducing inflammation, or developing into new blood vessel cells. Clinical trials have explored different cell types, injection methods, and patient populations. Some studies focus on patients with severe disease who aren’t candidates for traditional surgery, evaluating whether cell therapy can prevent amputation or improve wound healing^[2].

Advanced drug delivery systems are being studied to improve how medications reach diseased arteries. Drug-eluting stents are coated with medications that slowly release over time to prevent the artery from narrowing again—a problem called restenosis. Newer generations of these stents are being tested with different drug combinations and coating materials to improve long-term results. Some trials examine drug-coated balloons that deliver medication directly to the artery wall during angioplasty without leaving a permanent stent behind. This approach may be particularly useful for certain artery locations or patient groups^[10].

Researchers are also investigating novel antiplatelet and anticoagulant medications. These drugs prevent blood clots but need to balance effectiveness against bleeding risk. Clinical trials are testing new molecules that might offer better protection with fewer bleeding complications than current drugs. Some work by targeting different steps in the clotting process or by affecting how platelets interact with damaged artery walls. Phase III trials often compare these new medications head-to-head against standard treatments in large patient populations^[11].

Imaging technologies are advancing our ability to detect and monitor arterial disease. Clinical trials are evaluating new imaging methods that can identify dangerous plaques before they cause symptoms. These “vulnerable plaques” have characteristics that make them more likely to rupture and cause heart attacks or strokes. If doctors can identify them early, they might be able to intervene more aggressively to prevent events. Some trials test whether treating patients based on advanced imaging findings leads to better outcomes than current standard approaches^[9].

Minimally invasive catheter-based techniques continue to evolve. Researchers are developing new devices and approaches for removing plaque or opening blockages with less trauma to arteries. Some trials test devices that use different energy sources—such as laser, ultrasound, or orbital rotation—to treat difficult lesions that don’t respond well to standard balloon angioplasty. Others evaluate advanced imaging systems built into catheters that help doctors see exactly where and how to treat blockages during procedures^[15].

Clinical trials for arterial disease are conducted at major medical centers throughout the United States, Europe, and increasingly in other regions worldwide. Many trials are multicenter studies that enroll patients at numerous hospitals to gather enough data quickly. To find trials you might qualify for, you can search databases maintained by governments and research organizations, or ask your vascular specialist about studies at your treatment center. Some trials cover the costs of experimental treatments and study-related procedures, though policies vary^[4].

Phase I trials typically enroll small numbers of patients and focus primarily on safety—determining appropriate doses and identifying side effects. Phase II trials expand to larger groups, usually dozens to hundreds of patients, and begin evaluating whether the treatment shows promise for improving symptoms or other clinical measures. Phase III trials involve large patient populations, often thousands of people, and compare the new treatment directly against current standard treatments to see if it’s truly better. Only treatments that successfully complete all phases and gain regulatory approval become standard care options^[4].

Most common treatment methods

• Lifestyle modifications
  • Smoking cessation, which is the most important risk factor to address for preventing disease progression and complications
  • Supervised exercise training programs involving walking with rest periods to build collateral circulation
  • Heart-healthy diet emphasizing fruits, vegetables, whole grains, and healthy fats while limiting saturated fats and sodium
  • Weight management to reduce strain on the cardiovascular system
• Medication therapy
  • Antiplatelet drugs like aspirin and clopidogrel to prevent blood clots and reduce heart attack and stroke risk
  • Statins such as atorvastatin and simvastatin to lower cholesterol and stabilize arterial plaque
  • ACE inhibitors and ARBs to control blood pressure and provide cardiovascular protection
  • Medications like cilostazol to improve walking distance by widening blood vessels
  • Diabetes medications to control blood sugar levels in patients with diabetes
• Minimally invasive procedures
  • Balloon angioplasty to compress plaque and widen narrowed arteries using a catheter with an inflatable balloon
  • Stent placement to keep arteries open after angioplasty using metal mesh tubes
  • Atherectomy to remove hardened plaque using catheters with rotating blades or lasers
• Surgical treatment
  • Bypass surgery using veins from the leg or synthetic tubes to create detours around blocked arteries
  • Surgical procedures for severe blockages when minimally invasive approaches aren’t suitable
• Experimental therapies in clinical trials
  • Gene therapy to stimulate growth of new blood vessels through therapeutic angiogenesis
  • Cell-based therapies using stem cells or progenitor cells to improve blood flow and promote healing
  • Novel antiplatelet medications with improved safety profiles
  • Advanced drug-eluting stents and drug-coated balloons to prevent re-narrowing of arteries
  • Anti-inflammatory drugs targeting plaque formation processes